Mon panier

Human Glypican 3 (Gly510-Asn554) coupled magnetic beads (2 µm)

Numéro de produit/spécification
Prix
Qté
MBC-K200-2mg
$1150.00
MBC-K200-10mg (5mg X 2)
$4165.00
ETA of in-stock products:2 business days
Total des articles Montant du produit$ 0

Détails du produit

  • Items
    Size 2mg
    Size 10mg (5mg × 2)
    Particle size
    2 μm
    2 μm
    Physical appearance
    Powder mixture
    Powder mixture
    Source
    Gly510 - Asn554 (Accession # P51654)
    Gly510 - Asn554 (Accession # P51654)
    Amount of Coupled Protein
    >2299 pmol (20 μg) Glypican 3/mg beads
    >2299 pmol (20 μg) Glypican 3/mg beads
    Formulation
    PBS, pH7.4, with 10% Trehalose
    PBS, pH7.4, with 10% Trehalose
    Reconstitution
    2 mL sterile deionized water (1 mg beads/mL)
    5 mL sterile deionized water (1 mg beads/mL)
  • Product Description

    The Human Glypican 3-coupled Magnetic Beads is produced by coupling biotinylated human Glypican 3 protein to streptavidin-conjugated magnetic beads. The pre-coupled beads are ready to use for capturing anti-Glypican 3 antibody from your sample with high specificity. The uniform size and large surface-to-volume ratio of the beads ensure highly efficent immunocapture in a simple, fast and convenient workflow with high reproducibilty of data.

  • Application

    The beads is intended for immunocapture, biopanning. This is a non-sterile product.

    * The Isotype control (Cat. No. SMB-B01) is sold separately.

  • Storage

    This product is stable in storage under the following conditions: -20℃ for 24 months in lyophilized state.

    Please avoid more than 3 freeze-thaw cycles once reconstitution, immediate use after reconstitution is highly recommended.

  • ACRO Quality Management System

    1. QMS(ISO, GMP)
    2. Quality Advantages
    3. Quality Control Process

Les clients ont également consulté

Affichage des données

  • Typical Data

     Glypican 3 TYPICAL DATA

    Immobilized over 20 μg Biotinylated Human Glypican 3 protein on 1 mg Beads can bind the Anti-GPC3 Antibody with an EC50 of 0.147 μg/mL (QC tested).

    Protocol

Avis des utilisateurs
Publier un commentaire

Progrès de frontière

 
Progrès du développement médicamenteux
  • Nom anglais:

    Glypican-3

  • Catégorie:

  • Nombre de médicaments répertoriés:

    0 Détails

  • Nombre de médicaments cliniques:

    57 Détails

  • Étape de développement la plus élevée:

    Phase 2 Clinical

Drug Candidate Licensing
More
  • Informations de base sur le produit
  • Détails du produit
  • Les clients ont également consulté
  • Affichage des données
  • Avis des utilisateurs